wwwext.amgen.com
Locations | Amgen
http://wwwext.amgen.com/about/locations.html
Business Ethics and Compliance. Policies, Practices and Disclosures. Research and Development Strategy. Information for Healthcare Professionals. Clinical Trial Transparency, Data Sharing and Disclosure Practices. Clinical Out-of-Hours Support Program. Adverse Event and Product Complaint Reporting. About the Amgen Foundation. Reimbursement Support Services and Financial Assistance Programs. Access to Investigational Medicines. The Value of Our Medicines. Independent Medical Education Funding. Do you want...
gabionline.net
Home - GaBI Online - Generics and Biosimilars Initiative
http://www.gabionline.net/Generics/News/Generics-of-ADHD-drug-launched-in-US
Launches, approvals and court cases f. FDA approves first generic nilutamide. Glenmark gains approval for anti-epil. Dr Reddy’s to buy US generics from Teva. The satisfaction of healthcare payers. Ways to reduce drug costs in Australia. AES position statement on substitutio. Reasons for the success of a generics. EMA halts sales of unreliable generics. Extortionate increases in prices of 3. Healthcare alliance proposes ways to. China cuts prices for three drugs by. Mylan and Biocon submit pegfilgrastim.
gabionline.net
Home - GaBI Online - Generics and Biosimilars Initiative
http://www.gabionline.net/Generics/General/Soaring-generics-prices-come-under-increased-scrutiny
Launches, approvals and court cases f. FDA approves first generic nilutamide. Glenmark gains approval for anti-epil. Dr Reddy’s to buy US generics from Teva. The satisfaction of healthcare payers. Ways to reduce drug costs in Australia. AES position statement on substitutio. Reasons for the success of a generics. EMA halts sales of unreliable generics. Extortionate increases in prices of 3. Healthcare alliance proposes ways to. China cuts prices for three drugs by. Mylan and Biocon submit pegfilgrastim.
gabionline.net
Home - GaBI Online - Generics and Biosimilars Initiative
http://www.gabionline.net/Generics/News
Launches, approvals and court cases f. FDA approves first generic nilutamide. Glenmark gains approval for anti-epil. Dr Reddy’s to buy US generics from Teva. The satisfaction of healthcare payers. Ways to reduce drug costs in Australia. AES position statement on substitutio. Reasons for the success of a generics. EMA halts sales of unreliable generics. Extortionate increases in prices of 3. Healthcare alliance proposes ways to. China cuts prices for three drugs by. Mylan and Biocon submit pegfilgrastim.
gabionline.net
Home - GaBI Online - Generics and Biosimilars Initiative
http://www.gabionline.net/Advertise-form
Launches, approvals and court cases f. FDA approves first generic nilutamide. Glenmark gains approval for anti-epil. Dr Reddy’s to buy US generics from Teva. The satisfaction of healthcare payers. Ways to reduce drug costs in Australia. AES position statement on substitutio. Reasons for the success of a generics. EMA halts sales of unreliable generics. Extortionate increases in prices of 3. Healthcare alliance proposes ways to. China cuts prices for three drugs by. Mylan and Biocon submit pegfilgrastim.
amgen.com
Political Contributions | Amgen
http://www.amgen.com/about/corporate_governance_political_contributions.html
Business Ethics and Compliance. Policies, Practices and Disclosures. Research and Development Strategy. Information for Healthcare Professionals. Clinical Trial Transparency, Data Sharing and Disclosure Practices. Clinical Out-of-Hours Support Program. Adverse Event and Product Complaint Reporting. About the Amgen Foundation. Reimbursement Support Services and Financial Assistance Programs. Access to Investigational Medicines. The Value of Our Medicines. Independent Medical Education Funding. Do you want...
gabi-journal.net
Biosimilars: when indications can be extrapolated - GaBI Journal
http://gabi-journal.net/news/biosimilars-when-indications-can-be-extrapolated
Biosimilars: when indications can be extrapolated. Biosimilars: when indications can be extrapolated. Extrapolation* is already a well-established and accepted scientific and regulatory principle, according to members of the European Medicines Agency’s (EMA) Biosimilar Medicinal Products Working Party (BMWP) [1]. For biosimilars, extrapolation of efficacy and safety data from one indication to another may be considered if biosimilarity to the reference product has been shown by a comprehensive comparabil...
gabi-journal.net
Extrapolation of indications in biosimilars: filgrastim - GaBI Journal
http://gabi-journal.net/news/extrapolation-of-indications-in-biosimilars-filgrastim
Extrapolation of indications in biosimilars: filgrastim. Extrapolation of indications in biosimilars: filgrastim. Extrapolation* of indications for biosimilars is a contentious issue and has been met with concern by physicians. Members of the European Medicines Agency’s (EMA) Biosimilar Medicinal Products Working Party (BMWP) address these concerns using extrapolation of indications in biosimilar filgrastim as an example [1]. Pharmacokinetic profiles were comparable ensuring equivalent exposure. Comparab...
gabi-journal.net
Previous Issues - GaBI Journal
http://gabi-journal.net/gabi-journal/previous-issues
Recommend to a friend. Sign up today to receive news on the latest developments in generic and biosimilar medicines. Generics and Biosimilars Initiative (GaBI). Tel: 32 474989572 / Fax: 32 14 583 048.
SOCIAL ENGAGEMENT